This is part of the ongoing series of articles updating the evidence on current COVID-19 therapies. The rest of the series can be found here, and there is more to come. This article will cover the evidence for remdesivir in COVID-19. Remdesivir (GS-5734) is an antiviral drug that was originally […]
remdesivir
5 posts
The first RCT of remdesivir for COVID-19 was not encouraging, but even as it was being discussed, we knew that another trial existed, and we were told that the results were positive. The results of that trial (ACTT-1) are now out. The paper The ACTT-1 Trial: Beigel JH, Tomashek KM, […]
I hope to get back to normal emergency medicine literature sometime soon, but for now there is enough new COVID-19 research that I think another COVID specific research roundup is worthwhile. In this edition, I will tackle some more evidence that COVID can be spread by the airborne route, some […]
There was a bit of a social media fracas a few weeks ago when the first ‘trial’ of remdesivir for COVID-19 was published in the New England Journal of Medicine. (The journal being a red flag that you might be seeing advertising rather than real science). It was an uncontrolled […]
Last week, I discussed chloroquine (and hydroxychloroquine) for COVID, and the complete lack of convincing evidence. There are various other treatments that have been proposed, but none of them have strong evidence. However, seeing as COVID is a virus, I guess we should take some time to look at antiviral […]